Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
10.1038/nn804
Crossref journal-article
Springer Science and Business Media LLC
Nature Neuroscience (297)
Bibliography

Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002). Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nature Neuroscience, 5(3), 267–271.

Authors 8
  1. Andreas Meyer-Lindenberg (first)
  2. Robert S. Miletich (additional)
  3. Philip D. Kohn (additional)
  4. Giuseppe Esposito (additional)
  5. Richard E. Carson (additional)
  6. Mario Quarantelli (additional)
  7. Daniel R. Weinberger (additional)
  8. Karen Faith Berman (additional)
References 46 Referenced 511
  1. Bennett, M. R. Monoaminergic synapses and schizophrenia: 45 years of neuroleptics. J. Psychopharmacol. 12, 289–304 (1998). (10.1177/026988119801200310) / J. Psychopharmacol. by MR Bennett (1998)
  2. Kraepelin, E., Barclay, R. M. & Robertson, G. M. Dementia Præcox and Paraphrenia (E. & S. Livingstone, Edinburgh, 1919). / Dementia Præcox and Paraphrenia by E Kraepelin (1919)
  3. Lewis, D. A. & Anderson, S. A. The functional architecture of the prefrontal cortex and schizophrenia. Psychol. Med. 25, 887–894 (1995). (10.1017/S0033291700037375) / Psychol. Med. by DA Lewis (1995)
  4. Laruelle, M. & Abi-Dargham, A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J. Psychopharmacol. 13, 358–371 (1999). (10.1177/026988119901300405) / J. Psychopharmacol. by M Laruelle (1999)
  5. Jaskiw, G. E., Karoum, F. K. & Weinberger, D. R. Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain. Res. 534, 321–323 (1990). (10.1016/0006-8993(90)90149-6) / Brain. Res. by GE Jaskiw (1990)
  6. Pycock, C. J., Kerwin, R. W. & Carter, C. J. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286, 74–76 (1980). (10.1038/286074a0) / Nature by CJ Pycock (1980)
  7. Weinberger, D. R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660–669 (1987). (10.1001/archpsyc.1987.01800190080012) / Arch. Gen. Psychiatry by DR Weinberger (1987)
  8. Weinberger, D. R., Berman, K. F. & Illowsky, B. P. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry 45, 609–615 (1988). (10.1001/archpsyc.1988.01800310013001) / Arch. Gen. Psychiatry by DR Weinberger (1988)
  9. Grace, A. A. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J. Neural Transm. Gen. Sect. 91, 111–134 (1993). (10.1007/BF01245228) / J. Neural Transm. Gen. Sect. by AA Grace (1993)
  10. Deutch, A. Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. Suppl. 36, 61–89 (1992). / J. Neural Transm. Suppl. by AY Deutch (1992)
  11. Weinberger, D. R., Berman, K. F. & Zec, R. F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 43, 114–124 (1986). (10.1001/archpsyc.1986.01800020020004) / Arch. Gen. Psychiatry by DR Weinberger (1986)
  12. Weinberger, D. R. & Berman, K. F. Prefrontal function in schizophrenia: confounds and controversies. Phil. Trans. R. Soc. Lond. B Biol. Sci. 351, 1495–1503 (1996). (10.1098/rstb.1996.0135) / Phil. Trans. R. Soc. Lond. B Biol. Sci. by DR Weinberger (1996)
  13. Hietala, J. et al. Depressive symptoms and presynaptic dopamine function in neuroleptic- naive schizophrenia. Schizophr. Res. 35, 41–50 (1999). (10.1016/S0920-9964(98)00113-3) / Schizophr. Res. by J Hietala (1999)
  14. Hietala, J. et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346, 1130–1131 (1995). (10.1016/S0140-6736(95)91801-9) / Lancet by J Hietala (1995)
  15. Lindstrom, L. H. et al. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by l-(β-11C) DOPA and PET. Biol. Psychiatry 46, 681–688 (1999). (10.1016/S0006-3223(99)00109-2) / Biol. Psychiatry by LH Lindstrom (1999)
  16. Reith, J. et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc. Natl. Acad. Sci. USA 91, 11651–11654 (1994). (10.1073/pnas.91.24.11651) / Proc. Natl. Acad. Sci. USA by J Reith (1994)
  17. Dao-Castellana, M. H. et al. Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr. Res. 23, 167–174 (1997). (10.1016/S0920-9964(96)00102-8) / Schizophr. Res. by MH Dao-Castellana (1997)
  18. Elkashef, A. M. et al. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography. Psychiatry Res. 100, 1–11 (2000). (10.1016/S0925-4927(00)00064-0) / Psychiatry Res. by AM Elkashef (2000)
  19. Cumming, P., Kuwabara, H., Ase, A. & Gjedde, A. Regulation of DOPA decarboxylase activity in brain of living rat. J. Neurochem. 65, 1381–1390 (1995). (10.1046/j.1471-4159.1995.65031381.x) / J. Neurochem. by P Cumming (1995)
  20. Gjedde, A. et al. Dopa decarboxylase activity of the living human brain. Proc. Natl. Acad. Sci. USA 88, 2721–2725 (1991). (10.1073/pnas.88.7.2721) / Proc. Natl. Acad. Sci. USA by A Gjedde (1991)
  21. Abi-Dargham, A. et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761–767 (1998). (10.1176/ajp.155.11.1550) / Am. J. Psychiatry by A Abi-Dargham (1998)
  22. Wong, D. F. et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234, 1558–1563 (1986). (10.1126/science.2878495) / Science by DF Wong (1986)
  23. Abi-Dargham, A. et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. USA 97, 8104–8109 (2000). (10.1073/pnas.97.14.8104) / Proc. Natl. Acad. Sci. USA by A Abi-Dargham (2000)
  24. Bertolino, A. et al. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 22, 125–132 (2000). (10.1016/S0893-133X(99)00096-2) / Neuropsychopharmacology by A Bertolino (2000)
  25. Jackson, M. E., Frost, A. S. & Moghaddam, B. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens. J. Neurochem. 78, 920–923 (2001). (10.1046/j.1471-4159.2001.00499.x) / J. Neurochem. by ME Jackson (2001)
  26. Murase, S., Grenhoff, J., Chouvet, G., Gonon, F. G. & Svensson, T. H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157, 53–56 (1993). (10.1016/0304-3940(93)90641-W) / Neurosci. Lett. by S Murase (1993)
  27. Christie, M. J., Bridge, S., James, L. B. & Beart, P. M. Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res. 333, 169–172 (1985). (10.1016/0006-8993(85)90140-4) / Brain Res. by MJ Christie (1985)
  28. Kegeles, L. S. et al. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol. Psychiatry 48, 627–640 (2000). (10.1016/S0006-3223(00)00976-8) / Biol. Psychiatry by LS Kegeles (2000)
  29. Carr, D. B. & Sesack, S. R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20, 3864–3873 (2000). (10.1523/JNEUROSCI.20-10-03864.2000) / J. Neurosci. by DB Carr (2000)
  30. Carlsson, A. et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41, 237–260 (2001). (10.1146/annurev.pharmtox.41.1.237) / Annu. Rev. Pharmacol. Toxicol. by A Carlsson (2001)
  31. Saunders, R. C., Kolachana, B. S., Bachevalier, J. & Weinberger, D. R. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 393, 169–171 (1998). (10.1038/30245) / Nature by RC Saunders (1998)
  32. Swerdlow, N. R. & Geyer, M. A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24, 285–301 (1998). (10.1093/oxfordjournals.schbul.a033326) / Schizophr. Bull. by NR Swerdlow (1998)
  33. Grace, A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24 (1991). (10.1016/0306-4522(91)90196-U) / Neuroscience by AA Grace (1991)
  34. Daniel, D. G. et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 11, 1907–1917 (1991). (10.1523/JNEUROSCI.11-07-01907.1991) / J. Neurosci. by DG Daniel (1991)
  35. Okubo, Y. et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385, 634–636 (1997). (10.1038/385634a0) / Nature by Y Okubo (1997)
  36. Napier, T. C. & Chrobak, J. J. Evaluations of ventral pallidal dopamine receptor activation in behaving rats. Neuroreport 3, 609–611 (1992). (10.1097/00001756-199207000-00016) / Neuroreport by TC Napier (1992)
  37. Muller, U., von Cramon, D. Y. & Pollmann, S. D1- versus D2-receptor modulation of visuospatial working memory in humans. J. Neurosci. 18, 2720–2728 (1998). (10.1523/JNEUROSCI.18-07-02720.1998) / J. Neurosci. by U Muller (1998)
  38. Goldman-Rakic, P. S. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry 46, 650–661 (1999). (10.1016/S0006-3223(99)00130-4) / Biol. Psychiatry by PS Goldman-Rakic (1999)
  39. Weinberger, D. R. & Lipska, B. K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 16, 87–110 (1995). (10.1016/0920-9964(95)00013-C) / Schizophr. Res. by DR Weinberger (1995)
  40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R (American Psychiatric Association, Washington, DC, 1987).
  41. Miletich, R. S. et al. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys. Brain Res. 626, 1–13 (1993). (10.1016/0006-8993(93)90556-3) / Brain Res. by RS Miletich (1993)
  42. Berman, K. F. et al. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 33, 1027–1046 (1995). (10.1016/0028-3932(95)00035-2) / Neuropsychologia by KF Berman (1995)
  43. Woods, R. P., Mazziotta, J. C. & Cherry, S. R. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 17, 536–546 (1993). (10.1097/00004728-199307000-00004) / J. Comput. Assist. Tomogr. by RP Woods (1993)
  44. Talairach, J. & Tournoux, P. Co-planar Stereotaxic Atlas of the Human Brain (Thieme, Stuttgart New York, 1988). / Co-planar Stereotaxic Atlas of the Human Brain by J Talairach (1988)
  45. Brooks, D. J. et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann. Neurol. 28, 547–555 (1990). (10.1002/ana.410280412) / Ann. Neurol. by DJ Brooks (1990)
  46. Patlak, C. S., Blasberg, R. G. & Fenstermacher, J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3, 1–7 (1983). (10.1038/jcbfm.1983.1) / J. Cereb. Blood Flow Metab. by CS Patlak (1983)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:30 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 8:02 p.m.)
Indexed 1 day, 21 hours ago (Sept. 3, 2025, 6:13 a.m.)
Issued 23 years, 7 months ago (Jan. 28, 2002)
Published 23 years, 7 months ago (Jan. 28, 2002)
Published Online 23 years, 7 months ago (Jan. 28, 2002)
Published Print 23 years, 6 months ago (March 1, 2002)
Funders 0

None

@article{Meyer_Lindenberg_2002, title={Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia}, volume={5}, ISSN={1546-1726}, url={http://dx.doi.org/10.1038/nn804}, DOI={10.1038/nn804}, number={3}, journal={Nature Neuroscience}, publisher={Springer Science and Business Media LLC}, author={Meyer-Lindenberg, Andreas and Miletich, Robert S. and Kohn, Philip D. and Esposito, Giuseppe and Carson, Richard E. and Quarantelli, Mario and Weinberger, Daniel R. and Berman, Karen Faith}, year={2002}, month=jan, pages={267–271} }